Does needle biopsy encourage breast Ca spread?

Article

Women who receive fine-needle aspiration (FNA) or large-gauge needle core biopsy of breast cancer tissue are about 50% more likely to have sentinel node metastases than women who undergo tumor removal, according to a recent prospective database study from California.

Women who receive fine-needle aspiration (FNA) or large-gauge needle core biopsy of breast cancer tissue are about 50% more likely to have sentinel node metastases than women who undergo tumor removal, according to a recent prospective database study from California.

Researchers included 663 women with a mean age of 58 years and a mean tumor size of 1.85 cm. Women biopsied using FNA were about 53% more likely and those receiving large-gauge needle core biopsy were about 48% more likely to have their cancer spread to lymph nodes than women receiving excision.

Researchers surmise that the increased rate of spread has something to do with mechanical disruption of the tumor. The findings could be significant if one considers that the spread of cancer to the sentinel node decreases a woman's survival and influences the type of treatment she receives.

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
© 2024 MJH Life Sciences

All rights reserved.